Home › Funds › Western Standard LLC › ABUS
Western Standard LLC position in ABUS
ARBUTUS BIOPHARMA CORP · Health Care
Western Standard LLC reported holding 542,787 shares of ABUS (ARBUTUS BIOPHARMA CORP) in its Q2 2026 13F filing — a position valued at US$2.6M, representing 0.88% of its reported portfolio and ranking #21 among its reported holdings. Western Standard LLC has disclosed ABUS holdings in 4 of the last 4 reported quarters, going back to Q3 2025.
Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR
How Western Standard LLC's ABUS position evolved
Western Standard LLC first disclosed a stake in ABUS in Q3 2025 at 507,853 shares (US$2.3M). The position peaked in Q2 2026 at 542,787 shares, worth US$2.6M. Across 4 filings, Western Standard LLC increased the stake 2 time(s), trimmed it 0 time(s) and left it unchanged 1 time(s). The most recent filing (Q2 2026) shows 542,787 shares valued at US$2.6M — an increase of 21,200 shares quarter over quarter..
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q3 2025 | 507.85K | $2.31M | New |
| Q4 2025 | 507.85K | $2.44M | Hold |
| Q1 2026 | 521.59K | $2.35M | Add |
| Q2 2026 | 542.79K | $2.61M | Add |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About ABUS and 13F data
ABUS (ARBUTUS BIOPHARMA CORP) is a Health Care company. 43 other funds we track also report a position in ABUS — the largest reported positions include Whitefort Capital Management, LP (US$75.8M), Two Seas Capital LP (US$38.9M), BlackBarn Capital Partners LP (US$12.0M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding ABUS
- Whitefort Capital Management, LP 15.79M sh · $75.81M · Q2 2026
- Two Seas Capital LP 8.14M sh · $38.93M · Q3 2026
- BlackBarn Capital Partners LP 2.50M sh · $12.00M · Q2 2026
- Deltroit Asset Management (UK) LLP 1.20M sh · $5.76M · Q2 2026
- Rangeley Capital, LLC 500.00K sh · $2.40M · Q2 2026
More on Western Standard LLC
FAQ
How long has Western Standard LLC held ABUS?
Western Standard LLC has disclosed ABUS holdings in 4 of the last 4 reported quarters, going back to Q3 2025.
What is Western Standard LLC's current position in ABUS?
As of Q2 2026, Western Standard LLC holds 542.79K shares of ABUS (ARBUTUS BIOPHARMA CORP), valued at $2.61M, representing 0.88% of its reported portfolio and ranking #21.
Has Western Standard LLC been buying or selling ABUS?
In the latest 13F filing (Q2 2026), Western Standard LLC increased its position in ABUS. The position peaked in Q2 2026 at 542.79K shares.
Which other funds hold ABUS?
Other major institutional holders of ABUS include Whitefort Capital Management, LP, Two Seas Capital LP, BlackBarn Capital Partners LP, among 43 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.